Khayyat-Kholghi M, Oparil S, Davis BR, et al. Worsening kidney function is the major mechanism of heart failure in hypertension: The ALLHAT study. JACC Heart Fail. 2021;9(2):100–11.
Ostrominski JW, Arnold SV, Butler J, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999–2020. JAMA Cardiol. 2023;8(11):1050–60.
Marassi M, Fadini GP. The cardio-renal-metabolic connection: A review of the evidence. Cardiovasc Diabetol. 2023;22(1):195.
Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: A scientific statement from the American heart association. Circulation. 2023;148(20):1636–64.
Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-Kidney-Metabolic health: A presidential advisory from the American heart association. Circulation. 2023;148(20):1606–35.
Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic syndrome stages in US adults, 2011–2020. JAMA. 2024;331(21):1858–60.
Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829–30.
Khan SS, Coresh J, Pencina MJ, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-Kidney-Metabolic health: A scientific statement from the American heart association. Circulation. 2023;148(24):1982–2004.
Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: The epidemiology and risk factors. Circ Res. 2017;121(6):677–94.
Schauer PR, Mingrone G, Ikramuddin S, et al. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care. 2016;39(6):902–11.
Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life’s essential 8: updating and enhancing the American heart association’s construct of cardiovascular health: A presidential advisory from the American heart association. Circulation. 2022;146(5):e18–43.
Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting National goals for cardiovascular health promotion and disease reduction: the American heart association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.
Duan M, Zhao X, Li S, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001–2018. Cardiovasc Diabetol. 2024;23(1):243.
Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.
Li M, Chi X, Wang Y, et al. Trends in insulin resistance: Insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.
Rehni AK, Cho S, Dave KR. Ischemic brain injury in diabetes and Endoplasmic reticulum stress. Neurochem Int. 2022;152:105219.
Chang Y, Kim CK, Kim MK, et al. Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients. Sci Rep. 2021;11(1):1229.
Bello-Chavolla OY, Almeda-Valdes P, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.
Tian X, Chen S, Xu Q, et al. Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study. Cardiovasc Diabetol. 2023;22(1):339.
Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.
Qu L, Fang S, Lan Z, et al. Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS. Cardiovasc Diabetol. 2024;23(1):215.
National Center for Cardiovascular Diseases. China cardiovascular health and disease report 2023 [M]. Beijing: Peking Union Medical College; 2024.
Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M. Fukuoka stroke registry investigators. Insulin resistance and clinical outcomes after acute ischemic stroke. Neurology. 2018;90(17):e1470–7.
Jin A, Wang S, Li J, et al. Mediation of systemic inflammation on insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Stroke. 2023;54(3):759–69.
Zhou M, Li H, Wang Y, et al. Causal effect of insulin resistance on small vessel stroke and alzheimer’s disease: a Mendelian randomization analysis. Eur J Neurol. 2022;29(3):698–706.
Jing J, Pan Y, Zhao X, et al. Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: the ACROSS-China study (Abnormal glucose regulation in patients with acute stroke across China). Stroke. 2017;48(4):887–93.
Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 2013;339(6116):172–7.
Bloomgarden ZT. Obesity, hypertension, and insulin resistance. Diabetes Care. 2002;25(11):2088–97.
Zhao JV, Schooling CM. Sex-specific associations of insulin resistance with chronic kidney disease and kidney function: a bi-directional Mendelian randomisation study. Diabetologia. 2020;63(8):1554–63.
de Boer IH, Mehrotra R. Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment. Kidney Int. 2014;86(2):243–5.
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–23.
Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: past, present and future. Crit Rev Clin Lab Sci. 2015;52(4):180–90.
Yi J, Qu C, Li X, et al. Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis. Cardiovasc Diabetol. 2024;23(1):349.
Li F, Wang Y, Shi B, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23(1):16.
Salvetti A, Brogi G, Di Legge V, et al. The inter-relationship between insulin resistance and hypertension. Drugs. 1993;46(Suppl 2):149–59.
Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American heart association/american stroke association. Stroke. 2011;42(2):517–84.
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint National committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.
Zhou B, Perel P, Mensah GA, et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–802.
Lu J, Lu Y, Wang X et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017 9;390(10112):2549–2558. https://doi.org/10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5. Erratum in: Lancet. 2017 390(10112):2548.
Horn JW, Feng T, Mørkedal B, et al. Obesity and risk for first ischemic stroke depends on metabolic syndrome: the HUNT study. Stroke. 2021;52(11):3555–61.
Holmes MV, Millwood IY, Kartsonaki C, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71(6):620–32.
Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res. 2010;106(1):58–67.
Sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet. 2005;365(9459):610–2.
Moore SF, Williams CM, Brown E, et al. Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling. Cardiovasc Res. 2015;107(1):9–19.
Randriamboavonjy V, Fleming I. Insulin, insulin resistance, and platelet signaling in diabetes. Diabetes Care. 2009;32(4):528–30.
Vigili de Kreutzenberg S, Fadini GP, Boscari F, et al. Impaired hemodynamic response to meal intake in insulin-resistant subjects: an impedance cardiography approach. Am J Clin Nutr. 2011;93(5):926–33.
Glymour MM, Avendano M. Can self-reported strokes be used to study stroke incidence and risk factors? Evidence from the health and retirement study. Stroke. 2009;40(3):873–9.
Ilinca A, Kafantari E, Wallenius J, et al. Diagnosing Monogenic stroke at younger age. Stroke. 2024;55(12):2846–55.
Ekker MS, Verhoeven JI, Vaartjes I, et al. Stroke incidence in young adults according to age, subtype, sex, and time trends. Neurology. 2019;92(21):e2444–54.
Béjot Y, Daubail B, Jacquin A, et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon stroke registry. J Neurol Neurosurg Psychiatry. 2014;85(5):509–13.